An unblinded, randomized clinical trial involving 552 patients at UK found that among patients with hypertension at high risk of cardiovascular disease, self-monitoring with self-titration of antihypertensive medication compared with usual care resulted in lower systolic blood pressure at 12 months. The study was conducted between March 2011 and January 2013 in patients aged at least 35 years with a history of stroke, coronary heart disease, diabetes, or chronic kidney disease and with baseline blood pressure of at least 130/80 mm Hg. During the study period, the office visit blood pressure measurement target was 130/80 mm Hg and the home measurement target was 120/75 mm Hg. Previous study showed that the self-management strategy lowered blood pressure more than usual care in lower risk, mostly younger hypertension patients. Source: http://jama.jamanetwork.com/; http://www.ncbi.nlm.nih.gov/pubmed/20619448英国一项涉及552例患者的非盲随机对照临床试验发现，与常规治疗相比，心血管病风险高的高血压患者自我监测与自我调整抗高血压药物在12个月时的收缩压更低。这项研究是在2011年3月和2013年1月间进行，患者年龄至少35岁，有中风，冠心病，糖尿病或慢性肾脏疾病病史，基础血压至少130/80毫米汞柱。研究期间，在诊室随访的血压目标是130/80毫米汞柱，家庭测量血压目标是120/75毫米汞柱。以前已有研究表明，在风险较低且大多是年轻的高血压患者中，自我管理策略比常规治疗降压效果更显著。来源：http://jama.jamanetwork.com/; http://www.ncbi.nlm.nih.gov/pubmed/20619448
This website uses cookies.